CIC Exam Preparation Material with New CIC Dumps Questions [Q51-Q73]

5/5 - (2 votes)

CIC Exam Preparation Material with New CIC Dumps Questions

CIC 2026 Training With 174 QA’s

NO.51 A hospital is experiencing an increase in vancomycin-resistant Enterococcus (VRE) infections in the hematology-oncology unit. Which of the following interventions is MOST effective in halting the spread of VRE in this high-risk setting?

Screening all patients on admission and placing positive patients in isolation.

Restricting the use of vancomycin for all patients in the hospital.

Implementing a hand hygiene compliance audit and feedback system.

Conducting environmental sampling for VRE contamination weekly.

NO.52 A 36-year-old female presents to the Emergency Department with a petechial rash, meningitis, and cardiac arrest. During the resuscitation, a phlebotomist sustained a needlestick injury. The next day, blood cultures reveal Neisseria meningitidis. The exposure management for the phlebotomist is:

Prophylactic rifampin plus isoniazid.

A tuberculin skin test now and in ten weeks.

Work furlough from day ten to day 21 after exposure.

A review of the phlebotomist’s hepatitis B vaccine status.

The scenario involves a needlestick injury sustained by a phlebotomist during the resuscitation of a patient diagnosed with Neisseria meningitidis infection, characterized by a petechial rash, meningitis, and cardiac arrest. Neisseria meningitidis is a gram-negative diplococcus that can cause meningococcal disease, including meningitis and septicemia, and is transmitted through direct contact with respiratory secretions or, in rare cases, blood exposure. The exposure management for the phlebotomist must align with infection control guidelines, such as those from the Certification Board of Infection Control and Epidemiology (CBIC) and the CDC, to prevent potential infection. Let’s evaluate each option:
* A. Prophylactic rifampin plus isoniazid: Prophylactic antibiotics are recommended for close contacts of individuals with meningococcal disease to prevent secondary cases. Rifampin is a standard prophylactic agent for Neisseria meningitidis exposure, typically administered as a 2-day course (e.g., 600 mg every
12 hours for adults). Isoniazid, however, is used for tuberculosis (TB) prophylaxis and is not indicated for meningococcal disease. Combining rifampin with isoniazid is incorrect, as it reflects a confusion with TB management rather than meningococcal exposure. This option is not appropriate.
* B. A tuberculin skin test now and in ten weeks: A tuberculin skin test (TST) or interferon-gamma release assay (IGRA) is used to screen for latent tuberculosis infection, with a follow-up test at 8-10 weeks to detect conversion after potential TB exposure. Neisseria meningitidis is not related to TB, and a needlestick injury from a meningococcal patient does not warrant TB testing. This option is irrelevant to the scenario and not the correct exposure management.
* C. Work furlough from day ten to day 21 after exposure: Neisseria meningitidis has an incubation period of 2-10 days, with a maximum of about 14 days in rare cases. The CDC and WHO recommend that healthcare workers exposed to meningococcal disease via needlestick or mucosal exposure be monitored for signs of infection (e.g., fever, rash) and, if symptomatic, isolated and treated.
Additionally, a work restriction or furlough from day 10 to day 21 after exposure is advised to cover the potential incubation period, especially if prophylaxis is declined or contraindicated. This allows time to observe for symptoms and prevents transmission to vulnerable patients. This is a standard infection control measure and the most appropriate initial management step pending prophylaxis decision.
* D. A review of the phlebotomist’s hepatitis B vaccine status: Reviewing hepatitis B vaccine status is a critical step following a needlestick injury, as hepatitis B can be transmitted through blood exposure.
However, this applies to bloodborne pathogens (e.g., HBV, HCV, HIV) and is not specific to Neisseria meningitidis, which is primarily a respiratory or mucosal pathogen. While hepatitis B management (e.
g., post-exposure prophylaxis with hepatitis B immunoglobulin or vaccine booster) should be addressed as part of a comprehensive needlestick protocol, it is not the first or most relevant priority for meningococcal exposure.
The best answer is C, as the work furlough from day 10 to day 21 after exposure addresses the specific risk of meningococcal disease following a needlestick injury. This aligns with CBIC’s focus on timely intervention and work restriction to prevent transmission in healthcare settings. Prophylactic antibiotics (e.g., rifampin) should also be considered, but the question asks for the exposure management, and furlough is a primary control measure. Hepatitis B and TBconsiderations are secondary and managed separately.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which includes protocols for managing exposure to communicable diseases like meningococcal infection.
CBIC Examination Content Outline, Domain IV: Environment of Care, which addresses work restrictions and exposure management.
CDC Guidelines for Meningococcal Disease Prevention and Control (2023), which recommend work furlough and monitoring for exposed healthcare workers.

NO.53 A task force formed to focus on Clostridioides difficile infections (CDIs). The topic of the meeting discussed selecting the correct germicidal wipe. What important factor does the infection preventionist review?

Cost of a case of wipes

Size of individual wipes

Time the surface remains wet

Correct disposal of the wipe

The correct answer is C, “Time the surface remains wet,” as this is the most important factor the infection preventionist (IP) should review when selecting a germicidal wipe for controlling Clostridioides difficile infections (CDIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, effective environmental cleaning is a critical component of infection prevention, particularly for pathogens like C. difficile, which forms hardy spores that are resistant to many disinfectants. The efficacy of a germicidal wipe depends on the contact time-the duration the surface must remain wet with the disinfectant to ensure the killing of C. difficile spores. This is specified by the manufacturer and supported by guidelines from the Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA), which emphasize that the disinfectant must remain wet on the surface for the full recommended contact time (typically 1-10 minutes for sporicidal agents) to achieve the desired level of disinfection (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols).
Option A (cost of a case of wipes) is a practical consideration for budgeting but is secondary to efficacy in infection control, especially for a high-priority pathogen like C. difficile. Option B (size of individual wipes) may affect coverage and convenience but does not directly impact the wipe’s ability to eliminate the pathogen. Option D (correct disposal of the wipe) is important for preventing cross-contamination and ensuring compliance with waste management protocols, but it is a procedural step after use and not the primary factor in selecting the wipe.
The IP’s review of contact time aligns with CBIC’s focus on evidence-based practices to prevent healthcare- associated infections (HAIs). For C. difficile, which is a leading cause of HAIs, selecting a wipe with an appropriate sporicidal agent and ensuring adequate wet contact time is essential to disrupt transmission, particularly in outbreak settings (CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019). This factor directly influences the wipe’s effectiveness, making it the critical review point for the task force.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols. CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019.

NO.54 During the past week, three out of four blood cultures from a febrile neonate in an intensive care unit grew coagulase-negative staphylococci. This MOST likely indicates:

Laboratory error.

Contamination.

Colonization.

Infection.

The scenario involves a febrile neonate in an intensive care unit (ICU) with three out of four blood cultures growing coagulase-negative staphylococci (CoNS) over the past week. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes accurate interpretation of microbiological data in the
“Identification of Infectious Disease Processes” domain, aligning with the Centers for Disease Control and Prevention (CDC) guidelines for healthcare-associated infections. Determining whether this represents a true infection, contamination, colonization, or laboratory error requires evaluating the clinical and microbiological context.
Option B, “Contamination,” is the most likely indication. Coagulase-negative staphylococci, such as Staphylococcus epidermidis, are common skin flora and frequent contaminants in blood cultures, especially in neonates where skin preparation or sampling technique may be challenging. The CDC’s “Guidelines for the Prevention of Intravascular Catheter-Related Infections” (2017) and the Clinical and Laboratory Standards Institute (CLSI) note that multiple positive cultures (e.g., two or more) are typically required to confirm true bacteremia, particularly with CoNS, unless accompanied by clear clinical signs of infection (e.g., worsening fever, hemodynamic instability) and no other explanation. The inconsistency (three out of four cultures) and the neonate’s ICU setting-where contamination from skin or catheter hubs is common-suggest that the positive cultures likely result from contamination during blood draw rather than true infection. Studies, such as those in the Journal of Clinical Microbiology (e.g., Beekmann et al., 2005), indicate that CoNS in blood cultures is contaminated in 70-80% of cases when not supported by robust clinical correlation.
Option A, “Laboratory error,” is possible but less likely as the primary explanation. Laboratory errors (e.g., mislabeling or processing mistakes) could occur, but the repeated growth in three of four cultures suggests a consistent finding rather than a random error, making contamination a more plausible cause. Option C,
“Colonization,” refers to the presence of microorganisms on or in the body without invasion or immune response. While CoNS can colonize the skin or catheter sites, colonization does not typically result in positive blood cultures unless there is an invasive process, which is not supported by the data here. Option D,
“Infection,” is the least likely without additional evidence. True CoNS bloodstream infections (e.g., catheter- related) in neonates are serious but require consistent positive cultures, clinical deterioration (e.g., persistent fever, leukocytosis), and often imaging or catheter removal confirmation. The febrile state alone, with inconsistent culture results, does not meet the CDC’s criteria for diagnosing infection (e.g., at least two positive cultures from separate draws).
The CBIC Practice Analysis (2022) and CDC guidelines stress differentiating contamination from infection to avoid unnecessary treatment, which can drive antibiotic resistance. Given the high likelihood of contamination with CoNS in this context, Option B is the most accurate answer.
References:
* CBIC Practice Analysis, 2022.
* CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2017.
* Beekmann, S. E., et al. (2005). Coagulase-Negative Staphylococci in Blood Cultures. Journal of Clinical Microbiology.
* CLSI Guidelines on Blood Culture Interpretation, 2018.

NO.55 Which of the following processes is MOST important for the infection preventionist (IP) to review when evaluating a third-party reprocessor for single-use devices?

Observe all steps for reprocessing.

Review the facility’s blueprints and policies.

Ensure air and water cultures are performed regularly.

Obtain feedback from other IPs who use the reprocessor.

The correct answer is A, “Observe all steps for reprocessing,” as this is the most important process for the infection preventionist (IP) to review when evaluating a third-party reprocessor for single-use devices.
According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of single-use devices (SUDs) by third-party entities must adhere to stringent infection control standards to ensure they are safe for reuse and do not contribute to healthcare-associated infections (HAIs).
Observing all steps-such as cleaning, disinfection, sterilization, packaging, and quality control-allows the IP to directly assess compliance with manufacturer instructions, regulatory requirements (e.g., FDA guidelines), and best practices (e.g., AAMI ST91) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment). This hands-on evaluation is critical because any deviation in the reprocessing chain can compromise device sterility and patient safety.
Option B (review the facility’s blueprints and policies) provides context about the physical layout and procedural framework, but it is a preliminary step that does not directly verify the reprocessing process’s effectiveness. Option C (ensure air and water cultures are performed regularly) is important for monitoring environmental contamination risks, particularly in sterile processing areas, but it is a supportive measure rather than the primary focus of evaluating the reprocessor’s core activities. Option D (obtain feedback from other IPs who use the reprocessor) offers valuable peer insights, but it is subjective and secondary to direct observation, which provides firsthand evidence of compliance and performance.
The priority on observing reprocessing steps aligns with CBIC’s emphasis on ensuring the safety and efficacy of reprocessed medical devices, a key responsibility for IPs when outsourcing to third-party reprocessors (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 – Evaluate the environment for infection risks). This process enables the IP to identify specific weaknesses, validate adherence to standards, and make informed decisions about the reprocessor’s suitability.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 – Ensure safe reprocessing of medical equipment, 3.5 – Evaluate the environment for infection risks. AAMI ST91:2015, Flexible and semi-rigid endoscope processing in health care facilities.

NO.56 Which of the following processes is essential for endoscope reprocessing?

Intermediate level disinfection and contact time

Pre-cleaning, leak testing, and manual cleaning

Inspection using a borescope and horizontal storage

Leak testing, manual cleaning, and low level disinfection

The correct answer is B, “Pre-cleaning, leak testing, and manual cleaning,” as these processes are essential for endoscope reprocessing. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, proper reprocessing of endoscopes is critical to prevent healthcare-associated infections (HAIs), given their complex design and susceptibility to microbial contamination. The initial steps of pre-cleaning (removing gross debris at the point of use), leak testing (ensuring the endoscope’s integrity to prevent fluid ingress), and manual cleaning (using enzymatic detergents to remove organic material) are foundational to the reprocessing cycle. These steps prepare the endoscope for high-level disinfection or sterilization by reducing bioburden and preventing damage, as outlined in standards such as AAMI ST91 (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment). Failure at this stage can compromise subsequent disinfection, making it a non-negotiable component of the process.
Option A (intermediate level disinfection and contact time) is an important step but insufficient alone, as intermediate-level disinfection does not achieve the high-level disinfection required for semi-critical devices like endoscopes, which must eliminate all microorganisms except high levels of bacterial spores. Option C (inspection using a borescope and horizontal storage) includes valuable quality control (inspection) and storage practices, but these occur later in the process and are not essential initial steps; vertical storage is often preferred to prevent damage. Option D (leak testing, manual cleaning, and low level disinfection) includes two essential steps (leak testing and manual cleaning) but is inadequate because low-level disinfection does not meet the standard for endoscopes, which require high-level disinfection or sterilization.
The emphasis on pre-cleaning, leak testing, and manual cleaning aligns with CBIC’s focus on adhering to evidence-based reprocessing protocols to ensure patient safety and prevent HAIs (CBIC Practice Analysis,
2022, Domain III: Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols). These steps are mandated by guidelines to mitigate risks associated with endoscope use in healthcare settings.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.3 – Ensure safe reprocessing of medical equipment, 3.4 – Implement environmental cleaning and disinfection protocols. AAMI ST91:2015, Flexible and semi-rigid endoscope processing in health care facilities.

NO.57 There has been an outbreak of foodborne illness in the community believed to be associated with attendance at a church festival. Which of the following is the MOST appropriate denominator for calculation of the attack rate?

People admitted to hospitals with gastrointestinal symptoms

Admission tickets sold to the festival

Dinners served at the festival

Residents in the county who attended the festival

The attack rate, a key epidemiological measure in outbreak investigations, is defined as the proportion of individuals who become ill after exposure to a suspected source, calculated as the number of cases divided by the population at risk. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes accurate outbreak analysis in the “Surveillance and Epidemiologic Investigation” domain, aligning with the Centers for Disease Control and Prevention (CDC) “Principles of Epidemiology in Public Health Practice” (3rd Edition, 2012). The question involves a foodborne illness outbreak linked to a church festival, requiring the selection of the most appropriate denominator to reflect the population at risk.
Option D, “Residents in the county who attended the festival,” is the most appropriate denominator. The attack rate should be based on the total number of people exposed to the potential source of the outbreak (i.e., the festival), as this represents the population at risk for developing the foodborne illness. The CDC guidelines for foodborne outbreak investigations recommend using the number of attendees or participants as the denominator when the exposure is tied to a specific event, such as a festival. This approach accounts for all individuals who had the opportunity to consume the implicated food, providing a comprehensive measure of risk. Obtaining an accurate count of attendees may involve festival records, surveys, or estimates, but it directly reflects the exposed population.
Option A, “People admitted to hospitals with gastrointestinal symptoms,” is incorrect as a denominator. This represents the number of cases (the numerator), not the total population at risk. Using cases as the denominator would invalidate the attack rate calculation, which requires a distinct population base. Option B,
“Admission tickets sold to the festival,” could serve as a proxy for attendees if all ticket holders attended, but it may overestimate the at-risk population if some ticket holders did not participate or underestimate it if additional guests attended without tickets. The CDC advises using actual attendance data when available, making this less precise than Option D. Option C, “Dinners served at the festival,” is a potential exposure- specific denominator if the illness is linked to a particular meal. However, without confirmation that all cases are tied to a single dinner event (e.g., a specific food item), this is too narrow and may exclude attendees who ate other foods or did not eat but were exposed (e.g., via cross-contamination), making it less appropriate than the broader attendee count.
The CBIC Practice Analysis (2022) and CDC guidelines stress the importance of defining the exposed population accurately for attack rate calculations in foodborne outbreaks. Option D best captures the population at risk associated with festival attendance, making it the most appropriate denominator.
References:
* CBIC Practice Analysis, 2022.
* CDC Principles of Epidemiology in Public Health Practice, 3rd Edition, 2012.
* CDC Guidelines for Foodborne Disease Outbreak Response, 2017.

NO.58 Which of the following statements characterizes the proper use of chemical disinfectants?

All items to be processed must be cleaned prior to being submerged in solution.

The label on the solution being used must indicate that it kills all viable micro-organisms.

The solution should be adaptable for use as an antiseptic.

A chemical indicator must be used with items undergoing high-level disinfection.

The proper use of chemical disinfectants is a critical aspect of infection control, as outlined by the Certification Board of Infection Control and Epidemiology (CBIC). Chemical disinfectants are used to eliminate or reduce pathogenic microorganisms on inanimate objects, and their effective application requires adherence to specific protocols to ensure safety and efficacy. Let’s evaluate each option based on infection control standards:
* A. All items to be processed must be cleaned prior to being submerged in solution.: This statement is a fundamental principle of disinfectant use. Cleaning (e.g., removing organic material such as blood, tissue, or dirt) is a prerequisite before disinfection because organic matter can inactivate or reduce the effectiveness of chemical disinfectants. The CBIC emphasizes that proper cleaning is the first step in the disinfection process to ensure that disinfectants can reach and kill microorganisms. This step is universally required for all levels of disinfection (low, intermediate, and high), making it a characterizing feature of proper use.
* B. The label on the solution being used must indicate that it kills all viable micro-organisms.: This statement is misleading. No disinfectant can be guaranteed to kill 100% ofall viable microorganisms under all conditions, as efficacy depends on factors like contact time, concentration, and the presence of organic material. Disinfectant labels typically indicate the types of microorganisms (e.g., bacteria, viruses, fungi) and the level of disinfection (e.g., high-level, intermediate-level) they are effective against, based on standardized tests (e.g., EPA or FDA guidelines). Claiming that a solution kills all viable microorganisms is unrealistic and not a requirement for proper use; instead, the label must specify the intended use and efficacy, which varies by product.
* C. The solution should be adaptable for use as an antiseptic.: An antiseptic is a chemical agent used on living tissue (e.g., skin) to reduce microbial load, whereas a disinfectant is used on inanimate surfaces.
While some chemicals (e.g., alcohol) can serve both purposes, this is not a requirement for proper disinfectant use. The adaptability of a solution for antiseptic use is irrelevant to its classification or application as a disinfectant, which focuses on environmental or equipment decontamination. This statement does not characterize proper disinfectant use.
* D. A chemical indicator must be used with items undergoing high-level disinfection.: Chemical indicators (e.g., test strips or tapes) are used to verify that the disinfection process has met certain parameters (e.g., concentration or exposure time), particularly in sterilization or high-level disinfection (HLD). While this is a recommended practice for quality assurance in HLD (e.g., with glutaraldehyde or hydrogen peroxide), it is not a universal requirement for all chemical disinfectant use. HLD applies specifically to semi-critical items (e.g., endoscopes), and the need for indicators depends on the protocol and facility standards. This statement is too narrow and specific to characterize the proper use of chemical disinfectants broadly.
The correct answer is A, as cleaning prior to disinfection is a foundational and universally applicable step in the proper use of chemical disinfectants. This aligns with CBIC guidelines, which stress the importance of a clean surface to maximize disinfectant efficacy and prevent infection transmission in healthcare settings.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain IV:
Environment of Care, which mandates cleaning as a prerequisite for effective disinfection.
CBIC Examination Content Outline, Domain III: Prevention and Control of Infectious Diseases, which includes protocols for the proper use of disinfectants, emphasizing pre-cleaning.
CDC Guidelines for Disinfection and Sterilization in Healthcare Facilities (2021), which reinforce that cleaning must precede disinfection to ensure efficacy.

NO.59 Which humoral antibody indicates previous infection and assists in protecting tissue?

IgA

IgD

IgG

IgM

Humoral antibodies, or immunoglobulins, play distinct roles in the immune system, and their presence or levels can provide insights into infection history and ongoing immune protection. The Certification Board of Infection Control and Epidemiology (CBIC) recognizes the importance of understanding immunological responses in the “Identification of Infectious Disease Processes” domain, which is critical for infection preventionists to interpret diagnostic data and guide patient care. The question focuses on identifying the antibody that indicates a previous infection and assists in protecting tissue, requiring an evaluation of the functions and kinetics of the five major immunoglobulin classes (IgA, IgD, IgG, IgM, IgE).
Option C, IgG, is the correct answer. IgG is the most abundant antibody in serum, accounting for approximately 75-80% of total immunoglobulins, and is the primary antibody involved in long-term immunity. It appears in significant levels after an initial infection, typically rising during the convalescent phase (weeks to months after exposure) and persisting for years, serving as a marker of previous infection.
IgG provides protection by neutralizing pathogens, opsonizing them for phagocytosis, and activating the complement system, which helps protect tissues from further damage. The Centers for Disease Control and Prevention (CDC) and clinical immunology references, such as the “Manual of Clinical Microbiology” (ASM Press), note that IgG seroconversion or elevated IgG titers are commonly used to diagnose past infections (e.
g., measles, hepatitis) and indicate lasting immunity. Its ability to cross the placenta also aids in protecting fetal tissues, reinforcing its protective role.
Option A, IgA, is primarily found in mucosal secretions (e.g., saliva, tears, breast milk) and plays a key role in mucosal immunity, preventing pathogen adhesion to epithelial surfaces. While IgA can indicate previous mucosal infections and offers localized tissue protection, it is not the primary systemic marker of past infection or long-term tissue protection, making it less fitting. Option B, IgD, is present in low concentrations and is mainly involved in B-cell activation and maturation, with no significant role in indicating previous infection or protecting tissues. Option D, IgM, is the first antibody produced during an acute infection, appearing early in the immune response (within days) and indicating current or recent infection. However, its levels decline rapidly, and it does not persist to mark previous infection or provide long-term tissue protection, unlike IgG.
The CBIC Practice Analysis (2022) and CDC guidelines on serological testing emphasize IgG’s role in assessing past immunity, supported by immunological literature (e.g., Janeway’s Immunobiology, 9th Edition). Thus, IgG is the humoral antibody that best indicates previous infection and assists in protecting tissue, making Option C the correct choice.
References:
* CBIC Practice Analysis, 2022.
* Manual of Clinical Microbiology, ASM Press, 2019.
* Janeway’s Immunobiology, 9th Edition, 2016.
* CDC Serologic Testing Guidelines, 2014.

NO.60 During the last week in June, an emergency department log reveals numerous cases of profuse watery diarrhea in individuals 74 years of age and older. During the same time period, four immunocompromised patients were admitted with possible Cryptosporidium. Which of the following actions should the infection preventionist take FIKST?

Characterize the outbreak by person, place, and time

Increase surveillance facility wide for additional cases

Contact the laboratory to confirm stool identification results

Form a tentative hypothesis about the potential reservoir for this outbreak

When an outbreak of infectious disease is suspected, the first step is to conduct an epidemiologic investigation. This begins with characterizing the outbreak by person, place, and time to establish patterns and trends. This approach, known as descriptive epidemiology, provides critical insights into potential sources and transmission patterns.
Step-by-Step Justification:
* Identify Cases and Patterns:
* The infection preventionist should analyze patient demographics (person), locations of cases (place), and onset of symptoms (time). This helps in defining the outbreak scope and potential exposure sources.
* Create an Epidemic Curve:
* An epidemic curve helps determine whether the outbreak is a point-source or propagated event.
This can indicate whether the infection is spreading person-to-person or originating from a common source.
* Compare with Baseline Data:
* Reviewing historical data ensures that the observed cases exceed the expected norm, confirming an outbreak.
* Guide Further Investigation:
* Establishing basic epidemiologic patterns guides subsequent actions, such as laboratory testing, environmental sampling, and surveillance.
Why Other Options Are Incorrect:
* B. Increase surveillance facility-wide for additional cases:
* While enhanced surveillance is important, it should follow the initial characterization of the outbreak. Surveillance without a defined case profile may lead to misclassification and misinterpretation.
* C. Contact the laboratory to confirm stool identification results:
* Confirming lab results is essential but comes after defining the outbreak’s characteristics. Without an epidemiologic link, testing may yield results that are difficult to interpret.
* D. Form a tentative hypothesis about the potential reservoir for this outbreak:
* Hypothesis generation occurs after sufficient epidemiologic data have been collected. Jumping to conclusions without characterization may result in incorrect assumptions and ineffective control measures.
CBIC Infection Control References:
* APIC Text, “Outbreak Investigations,” Epidemiology, Surveillance, Performance, and Patient Safety Measures.
* APIC/JCR Infection Prevention and Control Workbook, Chapter 4, Surveillance Program.
* APIC Text, “Investigating Infectious Disease Outbreaks,” Guidelines for Epidemic Curve Analysis.

NO.61 An infection preventionist is preparing a report about an outbreak of scabies in a long-term care facility. How would this information be displayed in an epidemic curve?

List case names, room numbers, and date the infestation was identified using a logarithmic scale.

List case medical record numbers and the number of days in the facility to date of onset, showing data in a scatter plot.

Prepare a bar graph with no patient identifiers showing the number of cases over a specific period of time.

Prepare a scatter plot by patient location showing case prevalence over a specific period of time.

An epidemic curve, commonly used in infection prevention and control to visualize the progression of an outbreak, is a graphical representation of the number of cases over time. According to the principles outlined by the Certification Board of Infection Control and Epidemiology (CBIC), an epidemic curve is most effectively displayed using a bar graph or histogram that tracks the number of new cases by date or time interval (e.g., daily, weekly) without revealing patient identifiers, ensuring compliance with privacy regulations such as HIPAA. Option C aligns with this standard practice, as it specifies preparing a bar graph with no patient identifiers, focusing solely on the number of cases over a specific period. This allows infection preventionists to identify patterns, such as the peak of the outbreak or potential sources of transmission, while maintaining confidentiality.
Option A is incorrect because listing case names and room numbers with a logarithmic scale violates patient privacy and is not a standard method for constructing an epidemic curve. Logarithmic scales are typically used for data with a wide range of values, but they are not the preferred format for epidemic curves, which prioritize clarity over time. Option B is also incorrect, as using medical record numbers and scatter plots to show days in the facility to onset does not align with the definition of an epidemic curve, which focuses on case counts over time rather than individual patient timelines or scatter plot formats. Option D is inappropriate because a scatter plot by patient location emphasizes spatial distribution rather than the temporal progression central to an epidemic curve. While location data can be useful in outbreak investigations, it is typically analyzed separately from the epidemic curve.
The CBIC emphasizes the importance of epidemic curves in the “Identification of Infectious Disease Processes” domain, where infection preventionists use such tools to monitor and control outbreaks (CBIC Practice Analysis, 2022). Specifically, the use of anonymized data in graphical formats is a best practice to protect patient information while providing actionable insights, as detailed in the CBIC Infection Prevention and Control (IPC) guidelines.
References:
* CBIC Practice Analysis, 2022.
* CBIC Infection Prevention and Control Guidelines (IPC), Section on Outbreak Investigation and Epidemic Curve Construction.

NO.62 A surgeon approaches an infection preventionist (IP) concerned that there are more surgical site infections (SSIs) in hysterectomies performed in the facility’s stand-alone surgery center than in those performed in the acute-care operating room. The IP should

initiate prospective surveillance for SSIs in hysterectomies performed at the stand-alone surgery center

compare the most recent post-hysterectomy SSI surveillance data from the surgery center with those of the previous 12 months.

initiate post-hysterectomy SSI surveillance in hysterectomy patients to verify accuracy of current surveillance methodology

compare post-hysterectomy SSI rates in cases performed at the acute-care operating room with those performed at the surgery center.

NO.63 A city has a population of 150.000. Thirty new cases of tuberculosis (TB) were diagnosed in the city last year.
These now cases brought the total number of active TB cases in the city last year to 115. Which of the following equations represents the incidence rate tor TB per 100.000 in that year?

(30 ÷ 150.000) x 100.000 = X

(30÷ 150.000) x 100 = X

(115 ÷ 150.000) x 100.000 – X

(115 ÷ 100.000) x 100 = X

NO.64 An infection preventionist is evaluating a new catheter that may decrease the rate of catheter-associated urinary tract infections. Which of the following provides the BEST information to support the selection of this catheter?

Staff member preference and product availability

Product materials and vendor information

Value analysis and information provided by the manufacturer

Cost benefit analysis and safety considerations

The correct answer is D, “Cost benefit analysis and safety considerations,” as this provides the best information to support the selection of a new catheter aimed at decreasing the rate of catheter-associated urinary tract infections (CAUTIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, selecting medical devices like catheters for infection prevention involves a comprehensive evaluation that balances efficacy, safety, and economic impact. A cost-benefit analysis assesses the financial implications (e.g., reduced infection rates leading to lower treatment costs) against the cost of the new catheter, while safety considerations ensure the device minimizes patient risk, such as reducing biofilm formation or irritation that contributes to CAUTIs (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment). This dual focus provides evidence-based data to justify the catheter’s adoption, aligning with the goal of improving patient outcomes and reducing healthcare-associated infections (HAIs).
Option A (staff member preference and product availability) is subjective and logistical rather than evidence- based, making it insufficient for a decision that impacts infection rates. Option B (product materials and vendor information) offers technical details but lacks the broader context of efficacy and cost-effectiveness needed for a comprehensive evaluation. Option C (value analysis and information provided by the manufacturer) includes a structured assessment of value, but it may be biased toward the manufacturer’s claims and lacks the independent safety and cost-benefit perspective critical for infection prevention decisions.
The emphasis on cost-benefit analysis and safety considerations reflects CBIC’s priority on using data-driven and patient-centered approaches to select interventions that enhance infection control (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 – Use data to guide infection prevention and control strategies). This approach ensures the catheter’s selection is supported by robust evidence, optimizing both clinical and economic outcomes in the prevention of CAUTIs.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 – Use data to guide infection prevention and control strategies; Domain III: Infection Prevention and Control, Competency 3.3 – Ensure safe reprocessing of medical equipment.

NO.65 The infection preventionist (IP) is working with the Product Evaluation Committee to select a sporicidal disinfectant for Clostridioides difficile. An effective disinfectant for the IP to recommend is

quaternary ammonium compound.

phenolic.

isopropyl alcohol.

sodium hypochlorite.

The correct answer is D, “sodium hypochlorite,” as it is an effective sporicidal disinfectant for Clostridioides difficile that the infection preventionist (IP) should recommend. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, Clostridioides difficile (C. difficile) is a spore- forming bacterium responsible for significant healthcare-associated infections (HAIs), and its spores are highly resistant to many common disinfectants. Sodium hypochlorite (bleach) is recognized by the Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) as a sporicidal agent capable of inactivating C. difficile spores when used at appropriate concentrations (e.g., 1:10 dilution of household bleach) and with the recommended contact time (CBIC Practice Analysis, 2022, Domain III:
Infection Prevention and Control, Competency 3.4 – Implement environmental cleaning and disinfection protocols). This makes it a preferred choice for environmental disinfection in outbreak settings or areas with known C. difficile contamination.
Option A (quaternary ammonium compound) is effective against many bacteria and viruses but lacks sufficient sporicidal activity against C. difficile spores, rendering it inadequate for this purpose. Option B (phenolic) has broad-spectrum antimicrobial properties but is not reliably sporicidal and is less effective against C. difficile spores compared to sodium hypochlorite. Option C (isopropyl alcohol) is useful for disinfecting surfaces and killing some pathogens, but it is not sporicidal and evaporates quickly, making it ineffective against C. difficile spores.
The IP’s recommendation of sodium hypochlorite aligns with CBIC’s emphasis on selecting disinfectants based on their efficacy against specific pathogens and adherence to evidence-based guidelines (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 – Evaluate the environment for infection risks). Proper use, including correct dilution and contact time, is critical to ensure effectiveness, and the IP should collaborate with the Product Evaluation Committee to ensure implementation aligns with safety and regulatory standards (CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019).
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competencies 3.4 – Implement environmental cleaning and disinfection protocols, 3.5 – Evaluate the environment for infection risks. CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019.

NO.66 An 84-year-old male with a gangrenous foot is admitted to the hospital from an extended-care facility (ECF).
The ECF is notified that the wound grew Enterococcus faecium with the following antibiotic sensitivity results:
ampicillin – R
vancomycin – R
penicillin – R
linezolid – S
This is the fourth Enterococcus species cultured from residents within the same ECF wing in the past month.
The other cultures were from two urine specimens and a draining wound. The Infection Preventionist (IP) should immediately:

Notify the medical director of the outbreak.

Compare the four culture reports and sensitivity patterns.

Conduct surveillance cultures for this organism in all residents.

Notify the nursing administrator to close the wing to new admissions.

The scenario describes a potential outbreak of multidrug-resistant Enterococcus faecium in an extended-care facility (ECF) wing, indicated by four positive cultures (including the current case and three prior cases from urine and a draining wound) within a month. The organism exhibits resistance to ampicillin, vancomycin, and penicillin, but sensitivity to linezolid, suggesting a possible vancomycin-resistant Enterococcus (VRE) strain, which is a significant concern in healthcare settings. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes the importance of rapid outbreak detection and response in the
“Surveillance and Epidemiologic Investigation” domain, aligning with Centers for Disease Control and Prevention (CDC) guidelines for managing multidrug-resistant organisms (MDROs).
Option A, “Notify the medical director of the outbreak,” is the most immediate and critical action. Identifying an outbreak-defined by the CDC as two or more cases of a similar illness linked by time and place-requires prompt notification to the facility’s leadership (e.g., medical director) to initiate a coordinated response. The presence of four Enterococcus cases, including a multidrug-resistant strain, within a single ECF wing over a month suggests a potential cluster, necessitating urgent action to assess the scope, implement control measures, and allocate resources. The CDC’s “Management of Multidrug-Resistant Organisms in Healthcare Settings” (2006) recommends immediate reporting to facility leadership as the first step to activate an outbreak investigation team, making this the priority.
Option B, “Compare the four culture reports and sensitivity patterns,” is an important subsequent step in outbreak investigation. Analyzing the antibiotic susceptibility profiles and culture sources can confirm whether the cases are epidemiologically linked (e.g., clonal spread of VRE) and guide treatment and control strategies. However, this is a detailed analysis that follows initial notification and should not delay alerting the medical director. Option C, “Conduct surveillance cultures for this organism in all residents,” is a proactive measure to determine the prevalence of Enterococcus faecium, especially VRE, within the wing. The CDC recommends targeted surveillance during outbreaks, but this requires prior authorization and planning by the outbreak team, making it a secondary action after notification. Option D, “Notify the nursing administrator to close the wing to new admissions,” may be a control measure to prevent further spread, as suggested by the CDC for MDRO outbreaks. However, closing a unit is a significant decision that should be guided by the medical director and infection control team after assessing the situation, not an immediate independent action by the IP.
The CBIC Practice Analysis (2022) and CDC guidelines prioritize rapid communication with leadership to initiate a structured outbreak response, including resource allocation and policy adjustments. Given the multidrug-resistant nature and cluster pattern, notifying the medical director (Option A) is the most immediate and appropriate action to ensure a comprehensive response.
References:
* CBIC Practice Analysis, 2022.
* CDC Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006.

NO.67 An infection preventionist, Cancer Committee, and Intravenous Therapy Department are studying the incidence of infections in patients with triple lumen catheters. Which of the following is essential to the quality improvement process?

Establish subjective criteria for outcome measurement.

Recommendations for intervention must be approved by the governing board.

Study criteria must be approved monthly by the Cancer Committee.

A monitoring system must be in place following implementation of interventions.

The correct answer is D, “A monitoring system must be in place following implementation of interventions,” as this is essential to the quality improvement (QI) process. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, a key component of any QI initiative, such as studying the incidence of infections in patients with triple lumen catheters, is the continuous evaluation of interventions to assess their effectiveness and ensure sustained improvement. A monitoring system allows the infection preventionist (IP), Cancer Committee, and Intravenous Therapy Department to track infection rates, identify trends, and make data-driven adjustments to infection control practices post-intervention (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 – Evaluate the effectiveness of infection prevention and control interventions). This step is critical to validate the success of implemented strategies, such as catheter care protocols, and to prevent healthcare-associated infections (HAIs).
Option A (establish subjective criteria for outcome measurement) is not ideal because QI processes rely on objective, measurable outcomes (e.g., infection rates per 1,000 catheter days) rather than subjective criteria to ensure reliability and reproducibility. Option B (recommendations for intervention must be approved by the governing board) is an important step for institutional support and resource allocation, but it is a preparatory action rather than an essential component of the ongoing QI process itself. Option C (study criteria must be approved monthly by the Cancer Committee) suggests an unnecessary administrative burden; while initial approval of study criteria is important, monthly re-approval is not a standard QI requirement unless mandated by specific policies, and it does not directly contribute to the improvement process.
The emphasis on a monitoring system aligns with CBIC’s focus on using surveillance data to guide and refine infection prevention efforts, ensuring that interventions for triple lumen catheter-related infections are effective and adaptable (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 – Use data to guide infection prevention and control strategies). This approach supports a cycle of continuous improvement, which is foundational to reducing catheter-associated bloodstream infections (CABSI) in healthcare settings.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.4 – Evaluate the effectiveness of infection prevention and control interventions, 2.5 – Use data to guide infection prevention and control strategies.

NO.68 Operating room records indicate that 130 joint replacements have been performed. These include 70 total hip replacements, 55 total knee replacements, and 5 shoulder replacements. Two postoperative surgical site infections (SSIs) were identified in total hip replacements. What is the infection rate/100 procedures for total hip replacements?

1.5

2.9

3.3

3.6

NO.69 Therapeutic antimicrobial agents should be used when

the infecting agent is unknown

the patient’s illness warrants treatment prior to culture results

the patient symptoms suggest likely pathogens.

Following identification of the pathogen and sensitives.

NO.70 Which of the following is an example of an outcome measure?

Hand hygiene compliance rate

Adherence to Environmental Cleaning

Rate of multi-drug resistant organisms acquisition

Timing of preoperative antibiotic administration

The correct answer is C, “Rate of multi-drug resistant organisms acquisition,” as it represents an example of an outcome measure. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, outcome measures are indicators that reflect the impact or result of infection prevention and control interventions on patient health outcomes or the incidence of healthcare-associated infections (HAIs).
The rate of multi-drug resistant organisms (MDRO) acquisition directly measures the incidence of new infections caused by resistant pathogens, which is a key outcome affected by the effectiveness of infection control practices (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.4 – Evaluate the effectiveness of infection prevention and control interventions).
Option A (hand hygiene compliance rate) is an example of a process measure, which tracks adherence to specific protocols or practices intended to prevent infections, rather than the resulting health outcome. Option B (adherence to environmental cleaning) is also a process measure, focusing on the implementation of cleaning protocols rather than the end result, such as reduced infection rates. Option D (timing of preoperative antibiotic administration) is another process measure, assessing the timeliness of an intervention to prevent surgical site infections, but it does not directly indicate the outcome (e.g., infection rate) of that intervention.
Outcome measures, such as the rate of MDRO acquisition, are critical for evaluating the success of infection prevention programs and are often used to guide quality improvement initiatives. This aligns with CBIC’s emphasis on using surveillance data to assess the effectiveness of interventions and inform decision-making (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 – Use data to guide infection prevention and control strategies). The focus on MDRO acquisition specifically highlights a significant healthcare challenge, making it a prioritized outcome measure in infection control.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competencies 2.4 – Evaluate the effectiveness of infection prevention and control interventions, 2.5 – Use data to guide infection prevention and control strategies.

NO.71 What rate is expressed by the number of patients who acquire infections over a specified time period divided by the population at risk of acquiring an infection during that time period?

Incidence rate

Disease specific

Point prevalence

Period prevalence

NO.72 Which of the following statements describes the MOST important consideration of an infection preventionist when assessing the effectiveness of an infection control action plan?

Re-evaluate the action plan every three years.

Update the plan before the risk assessment is completed.

Develop a timeline and assign responsibilities for the stated action.

Monitor and validate the related outcome and process measures.

Assessing the effectiveness of an infection control action plan is a critical responsibility of an infection preventionist (IP) to ensure that interventions reduce healthcare-associated infections (HAIs) and improve patient safety. The Certification Board of Infection Control and Epidemiology (CBIC) highlights this process within the “Surveillance and Epidemiologic Investigation” and “Performance Improvement” domains, emphasizing the need for ongoing evaluation and data-driven decision-making. The Centers for Disease Control and Prevention (CDC) and other guidelines stress that the ultimate goal of an action plan is to achieve measurable outcomes, such as reduced infection rates, which requires systematic monitoring and validation.
Option D, “Monitor and validate the related outcome and process measures,” is the most important consideration. Outcome measures (e.g., infection rates, morbidity, or mortality) indicate whether the action plan has successfully reduced the targeted infection risk, while process measures (e.g., compliance with hand hygiene or proper catheter insertion techniques) assess whether the implemented actions are being performed correctly. Monitoring involves continuous data collection and analysis, while validation ensures the data’s accuracy and relevance to the plan’s objectives. The CBIC Practice Analysis (2022) underscores that effective infection control relies on evaluating both outcomes (e.g., decreased central line-associated bloodstream infections) and processes (e.g., adherence to aseptic protocols), making this a dynamic and essential step. The CDC’s “Compendium of Strategies to Prevent HAIs” (2016) further supports this by recommending regular surveillance and feedback as key to assessing intervention success.
Option A, “Re-evaluate the action plan every three years,” suggests a periodic review, which is a good practice for long-term planning but is insufficient as the most important consideration. Infection control requires more frequent assessment (e.g., quarterly or annually) to respond to emerging risks or outbreaks, making this less critical than ongoing monitoring. Option B, “Update the plan before the risk assessment is completed,” is illogical and counterproductive. Updating a plan without a completed risk assessment lacks evidence-based grounding, undermining the plan’s effectiveness and contradicting the CBIC’s emphasis on data-driven interventions. Option C, “Develop a timeline and assign responsibilities for the stated action,” is an important initial step in implementing an action plan, ensuring structure and accountability. However, it is a preparatory activity rather than the most critical factor in assessing effectiveness, which hinges on post- implementation evaluation.
The CBIC Practice Analysis (2022) and CDC guidelines prioritize outcome and process monitoring as the cornerstone of infection control effectiveness, enabling IPs to adjust strategies based on real-time evidence.
Thus, Option D represents the most important consideration for assessing an infection control action plan’s success.
References:
* CBIC Practice Analysis, 2022.
* CDC Compendium of Strategies to Prevent Healthcare-Associated Infections, 2016.

NO.73 Some pathogens live in the body and can be cultured, but do NOT elicit any response from the body’s defense mechanisms. This state is called:

Colonization

Infection

Latency

Contamination

The interaction between pathogens and the human body can take various forms, each with distinct immunological and clinical implications. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes understanding these states within the “Identification of Infectious Disease Processes” domain to guide infection prevention strategies. The question describes a scenario where pathogens are present, can be cultured (indicating viable organisms), but do not trigger a response from the body’s defense mechanisms, such as inflammation or immune activation. This requires identifying the appropriate microbiological state.
Option A, “Colonization,” is the correct answer. Colonization occurs when microorganisms are present on or in the body (e.g., skin, mucous membranes, or gut) without causing harm or eliciting an immune response.
These pathogens can be cultured, as they are alive and replicating, but they exist in a commensal or symbiotic relationship with the host, not provoking symptoms or defense mechanisms. Examples include normal flora like Staphylococcus epidermidis on the skin or Streptococcus salivarius in the oral cavity. The Centers for Disease Control and Prevention (CDC) defines colonization as the presence of microbes without tissue invasion or damage, distinguishing it from infection (CDC, “Principles of Epidemiology in Public Health Practice,” 3rd Edition, 2012).
Option B, “Infection,” is incorrect because it involves the invasion and multiplication of pathogens in body tissues, leading to an immune response, such as inflammation, fever, or antibody production. This contrasts with the question’s description of no defense mechanism response. Option C, “Latency,” refers to a state where a pathogen (e.g., herpes simplex virus or Mycobacterium tuberculosis) remains dormant in the body after initial infection, capable of reactivation but not eliciting an active immune response during dormancy.
However, latency implies a prior infection with a latent phase, whereas the question suggests a current, non- responsive state without prior infection context. Option D, “Contamination,” describes the unintended presence of pathogens on inanimate objects or surfaces (e.g., medical equipment), not within the body, and does not align with the scenario of living, culturable pathogens in a host.
The CBIC Practice Analysis (2022) and CDC guidelines highlight colonization as a key concept in infection control, particularly in settings like hospitals where colonized patients can serve as reservoirs for potential infections. The absence of an immune response, as specified, aligns with the definition of colonization, making Option A the most accurate answer.
References:
* CBIC Practice Analysis, 2022.
* CDC Principles of Epidemiology in Public Health Practice, 3rd Edition, 2012.